Profile
Ryszard Kole worked as the Senior Vice President-Discovery Research at Sarepta Therapeutics, Inc. Prior to that, he was the President & Chief Scientific Officer at Ercole Biotech, Inc. He also worked as a Professor-Pharmacology Department at The University of North Carolina at Charlotte.
Kole holds a doctorate degree from the Polish Academy of Sciences.
Former positions of Ryszard Kole
| Companies | Position | End |
|---|---|---|
Ercole Biotech, Inc.
 Ercole Biotech, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Sarepta Therapeutics, Inc., Ercole Biotech, Inc. develops splice switching drugs for the treatment of major human diseases. The company is based in Research Triangle Park, NC. The company was founded by Jorn Gorlach. Ercole Biotech was acquired by Sarepta Therapeutics, Inc. on March 20, 2008 for $8.25 million. | President | - |
| The University of North Carolina at Charlotte | Corporate Officer/Principal | - |
| SAREPTA THERAPEUTICS, INC. | Corporate Officer/Principal | - |
Training of Ryszard Kole
| Polish Academy of Sciences | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| SAREPTA THERAPEUTICS, INC. | Health Technology |
| Private companies | 1 |
|---|---|
Ercole Biotech, Inc.
Ercole Biotech, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Sarepta Therapeutics, Inc., Ercole Biotech, Inc. develops splice switching drugs for the treatment of major human diseases. The company is based in Research Triangle Park, NC. The company was founded by Jorn Gorlach. Ercole Biotech was acquired by Sarepta Therapeutics, Inc. on March 20, 2008 for $8.25 million. | Commercial Services |
- Stock Market
- Insiders
- Ryszard Kole
